✦ LIBER ✦

Combination of irinotecan and anti-death receptor 5 antibody inhibits pancreatic cancer in an orthotopic tumor model

✍ Scribed by L.C. DeRosier; D.J. Buchsbaum; J.C. Sellers; Z.Q. Huang; P.G. Oliver; S.M. Vickers

Book ID: 116702184
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 71 KB
Volume: 130
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2005.11.164

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined therapy with anti-death recepto

Combined therapy with anti-death receptor-5 antibody and triptolide induces apoptosis in pancreatic cancer cells

✍ Daniel Borja-Cacho; Zwolak Pawel; Yumi Yokoyama; Jacob S. Ankeny; Mara B. Antono 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Anti-tumor activity of TRA-8 anti-death

Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model

✍ J. Michael Straughn Jr.; Patsy G. Oliver; Tong Zhou; Wenquan Wang; Ronald D. Alv 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 582 KB

45: Treatment with a monoclonal death re

45: Treatment with a monoclonal death receptor-5 antibody and Irinotecan increases survival in a radiologically verified model of pancreatic cancer

✍ L.C. Derosier; D.J. Buchsbaum; J. Sellers; Z.Q. Huang; P.G. Oliver; W. Wang; Z. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Combination of a monoclonal anti-phospha

Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice

✍ Adam W. Beck; Troy A. Luster; Andrew F. Miller; Shane E. Holloway; Chris R. Conn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 277 KB

## Abstract Pancreatic cancer continues to have a dismal prognosis and novel therapy is needed. In this study, we evaluate a promising new target for therapy, phosphatidylserine (PS). PS is an anionic phospholipid located normally on the inner leaflet of the plasma membrane in mammalian cells. In t

Anti-tumor activity of an anti-DR5 monoc

Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model

✍ Kerri S. Bevis; Lacey R. McNally; Jeffery C. Sellers; Deborah Della Manna; Angel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 847 KB

Connective tissue growth factor-specific

Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer

✍ Aikawa, T. 📂 Article 📅 2006 🏛 American Association for Cancer Research 🌐 English ⚖ 321 KB